Publications by authors named "Praveena Karnati"
Asian J Psychiatr
December 2024
Article Synopsis
- * The text discusses key psychedelic substances (e.g., psilocybin, MDMA, LSD) and their therapeutic potential, mechanisms, and the current regulatory landscape involving their legal status, particularly their classification as Schedule I substances.
- * Regulatory bodies like the FDA and EMA are monitoring psychedelic development closely, emphasizing the need for careful regulation to ensure safety, efficacy, and the therapeutic benefits of these drugs.
